Molecular signatures of atherosclerotic plaques: An up-dated panel of protein related markers

S Eslava-Alcon1, M J Extremera-García1, A González-Rovira1

  • 1Biomedicine, Biotechnology and Public Health Department, Cadiz University, Spain; Institute of Biomedical Research Cadiz (INIBICA), Spain.

Journal of Proteomics
|April 5, 2020
PubMed

Insights

Identifying vulnerable atherosclerotic plaques is crucial for preventing heart attacks and strokes. Researchers propose a panel of 76 proteins as a potential signature for plaque instability, aiding risk assessment.

Area of Science:

  • Cardiovascular Research
  • Proteomics
  • Biomarker Discovery

Background:

  • Atherosclerosis is a leading cause of ischemic events like myocardial infarction and stroke.
  • Plaque rupture and arterial blockage are primary drivers of these events.
  • Identifying high-risk plaques is essential for timely patient intervention.

Purpose of the Study:

  • To address the challenge of identifying vulnerable atherosclerotic plaques.
  • To propose a multi-protein signature for assessing plaque instability.
  • To improve risk stratification for patients with atherosclerosis.

Main Methods:

  • Review and selection of proteins from proteomic studies on unstable atherosclerotic plaques.
  • Identification of 76 candidate proteins based on presence in at least two studies.
  • Focus on both classical inflammatory and newly identified molecular markers.

Main Results:

  • A comprehensive panel of 76 proteins associated with atherosclerotic plaque instability was curated.
  • This panel includes diverse markers, from inflammatory proteins to novel candidates.
  • The selected proteins have been identified in multiple proteomic analyses of unstable plaques.

Conclusions:

  • A single molecular marker is insufficient to predict plaque rupture due to disease complexity.
  • A panel of 76 proteins offers a more accurate prognostic signature for plaque instability.
  • This protein signature could enhance the identification of patients at risk of occlusive events.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
667
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
454
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
702
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
375
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
294
Inflammation01:38

Inflammation

Overview
61.2K